TREATMENT OF METASTATIC MELANOMA WITH INTERLEUKIN-2

被引：0
作者：
CHOSIDOW, O
GUILLAUME, JC
机构：
[1] HOP HENRI MONDOR,SERV DERMATOL,F-94010 CRETEIL,FRANCE
[2] INST GUSTAVE ROUSSY,SERV DERMATOL,F-94805 VILLEJUIF,FRANCE
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 1992年 / 119卷 / 01期
关键词：
MALIGNANT MELANOMA; INTERLEUKIN-2;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：65 / 73
页数：9
相关论文
共 50 条
[31]   Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma [J].
Eton, O ;
Rosenblum, MG ;
Legha, SS ;
Zhang, WH ;
East, MJ ;
Bedikian, A ;
Papadopoulos, N ;
Buzaid, A ;
Benjamin, RS .
CANCER, 2002, 95 (01) :127-134
[32]   VITILIGO-LIKE LEUKODERMA IN METASTATIC MELANOMA TREATED WITH INTERLEUKIN-2 - 4 CASES [J].
WOLKENSTEIN, P ;
CHOSIDOW, O ;
GUILLAUME, JC ;
WECHSLER, J ;
AVRIL, MF ;
REVUZ, J .
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1992, 119 (11) :907-909
[33]   THE HEMATOLOGIC TOXICITY OF INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA AND RENAL-CELL CARCINOMA [J].
MACFARLANE, MP ;
YANG, JC ;
GULERIA, AS ;
WHITE, RL ;
SEIPP, CA ;
EINHORN, JH ;
WHITE, DE ;
ROSENBERG, SA .
CANCER, 1995, 75 (04) :1030-1037
[34]   Intra-lesional Interleukin-2 for the Treatment of In-Transit Melanoma [J].
Boyd, Kirsty U. ;
Wehrli, Bret M. ;
Temple, Claire L. F. .
JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (07) :711-717
[35]   ANTITUMOR EFFECTS OF POLYVALENT AND MONOVALENT VACCINES COUPLED WITH INTERLEUKIN-2 IN A METASTATIC MELANOMA MODEL [J].
SHRAYER, D ;
KONESS, J ;
KOUTTAB, N ;
BOGAARS, H ;
HEARING, VJ ;
MAIZEL, A ;
WANEBO, HJ .
INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (05) :1121-1127
[36]   Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-α-2a in patients with metastatic melanoma [J].
Dorval, T ;
Négrier, S ;
Chevreau, C ;
Avril, MF ;
Baume, D ;
Cupissol, D ;
Oskam, R ;
de Peuter, R ;
Vinke, J ;
Herrera, L ;
Escudier, B .
CANCER, 1999, 85 (05) :1060-1066
[37]   Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a - Implications for the treatment of patients with metastatic melanoma [J].
Eton, O ;
Talpaz, M ;
Lee, KH ;
Rothberg, JM ;
Brell, JM ;
Benjamin, RS .
CANCER, 1996, 77 (05) :893-899
[38]   Intra-Lesional Interleukin-2 Therapy for In Transit Melanoma [J].
Temple-Oberle, Claire F. ;
Byers, Brett A. ;
Hurdle, Valerie ;
Fyfe, Allison ;
Mckinnon, J. Gregory .
JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (04) :327-331
[39]   High-Dose Intensity Pulse Interleukin-2 with Famotidine Has Activity in Metastatic Melanoma [J].
Quan, Walter D. Y., Jr. ;
Walker, Paul R. ;
Picton, Maria ;
Quan, Francine M. ;
King, Linda A. ;
Tyre, Charley ;
Liles, Darla K. .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (05) :641-646
[40]   Cisplatin, interleukin-2, interferon-α and tamoxifen in metastatic melanoma.: A phase II study [J].
Naglieri, E ;
Procacci, A ;
Galetta, D ;
Abbate, I ;
Dell'Erba, L ;
Colucci, G .
JOURNAL OF CHEMOTHERAPY, 1999, 11 (02) :150-155
12345